TTAM (TTAM) Stock Price & Analysis
TTAM (TTAM) rose 1.00% to USD 17.15 as of July 26, 2026 at 08:06 UTC, according to Nexqual real-time market data.
TTAM last closed at USD 16.98; the session ranged USD 16.74–17.39 on volume of 188,245 shares. Market capitalization is $3.16B, with a 52-week range of USD 13.29–19.57 (NYQ). Source: Nexqual, July 26, 2026 at 08:06 UTC.
Key Statistics (as of July 26, 2026 at 08:06 UTC)
| Price | USD 17.15 |
|---|---|
| Change | ▲ 1.00% (up) |
| Previous Close | USD 16.98 |
| Open | USD 16.94 |
| Day Range | USD 16.74 – 17.39 |
| 52-Week Range | USD 13.29 – 19.57 |
| Volume | 188,245 shares |
| Market Cap | $3.16B |
| Exchange | NYQ |
Technical Analysis (TTAM)
Nexqual's technical model rates TTAM "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of July 26, 2026 at 08:06 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 53.07 (neutral) |
| vs SMA50 | Above (USD 16.88) |
| MACD | -0.09 (negative) |
Analyst Ratings (TTAM)
Wall Street analysts rate TTAM "Hold" based on 7 analysts, with a mean price target of USD 18.21 (range USD 15–22), per Nexqual as of July 26, 2026 at 08:06 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 7 |
| Mean Target | USD 18.21 |
| High Target | USD 22 |
| Low Target | USD 15 |
| Buy / Hold / Sell | 2 / 4 / 1 |
Earnings (TTAM)
| Next Earnings Date | 2026-07-28 |
|---|---|
| EPS Estimate | USD 0.27 |
| Revenue Estimate | $444.49M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.2 vs est 0.2 ▼ miss |
| 2025-12-31 | USD 0.26 vs est 0.24 ▲ beat |
| 2025-09-30 | USD 0.33 vs est 0.31 ▲ beat |
| 2025-06-30 | USD 0.27 vs est 0.31 ▼ miss |
Source: Nexqual, July 26, 2026 at 08:06 UTC.
Financials & Fundamentals (TTAM)
| Total Revenue | $1.67B |
|---|---|
| Revenue Growth (YoY) | +1.50% |
| Gross Margin | +27.16% |
| Operating Margin | +12.50% |
| Profit Margin | +11.08% |
| ROE | +18.72% |
| Debt / Equity | 42.89 |
| Current Ratio | 2.99 |
| Total Cash | $228.25M |
| Total Debt | $455.24M |
| Free Cash Flow | $111.26M |
Source: Nexqual, July 26, 2026 at 08:06 UTC.
Financial Health Score (TTAM)
Nexqual rates TTAM's overall financial health "Solid" across five dimensions, as of July 26, 2026 at 08:06 UTC.
| Growth | Mixed — Revenue +1.8% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 27%, operating 12% |
| Balance Sheet | Strong — $228M cash vs $455M debt |
| Cash Flow | Solid — FCF $111M, 7% margin |
| Efficiency | Solid — ROE 19%, ROA 9.1% |
Ownership (TTAM)
| Insider Ownership | +86.68% |
|---|---|
| Institutional Ownership | +16.20% |
| Shares Outstanding | 184.36M |
| Float | 24.55M |
| Short % of Float | +11.13% |
Source: Nexqual, July 26, 2026 at 08:06 UTC.
Leadership (TTAM)
TTAM is led by Vassilios S. Zarkalis (age 64), President, CEO & Director, per Nexqual as of July 26, 2026 at 08:06 UTC.
| President, CEO & Director | Vassilios S. Zarkalis (age 64) |
|---|---|
| Chief Financial Officer | Lawrence H. Wilt (age 60) |
| President of Titan Mid-Atlantic | Kevin Baird (age 57) |
| President of Florida Business Unit | Jason Morin (age 53) |
| Executive Director of Growth & Strategy | Randy Dunlap (age 70) |
Major Backers & Investors (TTAM)
Notable institutional backers of TTAM include American Century Companies Inc, Victory Capital Management Inc., River Road Asset Management, LLC, according to Nexqual as of July 26, 2026 at 08:06 UTC.
Active Investors
| Investor | Stake |
|---|---|
| American Century Companies Inc | 3.76% |
| Victory Capital Management Inc. | 2% |
| River Road Asset Management, LLC | 1.61% |
| Voss Capital, LP | 1.6% |
| Victory Portfolios-Victory Sycamore Small Company Opportunity Fund | 1.42% |
| Allspring Global Investments Holdings, LLC | 1.25% |
| GLOBAL X FUNDS-Global X US Infrastructure Development ETF | 1.23% |
| Mirae Asset Global ETFs Holdings Ltd. | 1.19% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 0.98% |
Source: Nexqual, July 26, 2026 at 08:06 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AMRZ | Amrize Ltd | USD 49.25 | ▼ 0.63% |
| FLOC | Flowco Holdings Inc. | USD 20.15 | ▼ 2.47% |
| KNF | Knife Riv Holding Co. | USD 78.06 | ▼ 1.82% |
| SION | Sionna Therapeutics, Inc. | USD 45.7 | ▲ 1.49% |
| KMTS | Kestra Medical Technologies, Lt | USD 21.06 | ▲ 0.81% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 08:06 UTC. This page is informational and not investment advice.